19 research outputs found
Clinical and radiological consequences of delayed therapy escalation in patients with relapsing-remitting multiple sclerosis
Aim of the study. To evaluate the clinical and radiological consequences of delayed escalation of therapy in patients with relapsing-remitting multiple sclerosis (RRMS), in whom, despite finding platform therapy ineffective, high-efficacy drugs were introduced with a delay.
Material and methods. We performed a single-centre, observational study evaluating patients with RRMS for ineffectiveness of disease-modifying therapies (DMTs). Depending on the time of therapy escalation to high-efficacy drugs, the patients were divided into an early escalation or a late escalation group, both of which were then observed for 48 months. All patients underwent a neurological examination every six months and a brain magnetic resonance imaging (MRI) every 12 months. The primary endpoint was a change in the Expanded Disability Status Scale (EDSS) score during the observation period. The secondary endpoint was the time to 6-month confirmed disability progression (6mCDP). In addition, we analysed the annualised relapse rate and the cumulative number of new Gd+ and T2 lesions on brain MRI.
Results. 165 patients were qualified for the analysis. On treatment initiation, mean age was 38 years (± 10.9), and mean EDSS was 1.41 ± 0.38. After 48 months, there was a statistically insignificant decrease in the EDSS score in the early escalation group (–0.17 ± 0.35; p > 0.05), while in the late escalation group there was an increase in the EDSS score. The highest increase was noted in the group in which the escalation was performed with a delay of more than two years (1.2 ± 0.63; p < 0.001), and moreover 80% of patients in this group met the 6mCDP criteria. The median time to 6mCDP was 4.6 years (LESC1) and 4.5 years (LESC2) in the late escalation groups. In the early escalation group, zero subjects met the 6mCDP criteria after 48 months of observation.
Conclusions. In everyday practice, the long-term outcomes in patients with RRMS and disease activity, despite DMT being used, are more favourable after early implementation of high-efficacy drugs. Delaying therapy escalation results in the accumulation of permanent disability in patients with RRMS
Objective assessment of dysarthric disorders in patients with multiple sclerosis depending on sex, age, and type of text read
PurposeTo assess dysarthric disorders in multiple sclerosis (MS) patients in comparison with healthy individuals and MS patients without dysarthria depending on the patient’s sex, age, and the type of text read using an objective tool.MethodsThe study was carried out in a group of 72 persons, including 24 with MS presenting dysarthria (study group) and 24 healthy individuals (healthy control group), and 24 with MS without dysarthria (MS control group). Performance (reading) time was evaluated by means of an objective tool created for the purpose of the analysis.ResultsThe study showed significant statistical differences in the analyzed performance time of: poetry reading, prose reading, and completing a diction exercise, among persons with MS from the study group presenting dysarthria and both control groups (p < 0.05). It took more time to read the poem, and prose and to perform a diction exercise in the study group with dysarthria than in both control groups (with no significant differences between the two) Similarly, the comparison between the groups in terms of sex and age showed disturbances in the above-mentioned parameter in the study group. What was not demonstrated were significant differences in the evaluated speech parameters depending on both sex and age separately in the group of MS patients with dysarthria, and both control groups (p < 0.05).ConclusionThe objective tool created for the purpose of speech analysis is useful in detecting discrepancies in performance (reading) time among MS patients with dysarthria, and healthy individuals, as well as patients with MS without dysarthria and can be used in clinical practice for diagnostic purposes, however, further research is essential to complete its validation
Omdlenie sercowe i omdlenie neurogenne u pacjenta po przebytym zawale serca z nierozpoznanym pierwotnie napadowym trzepotaniem przedsionków
Sense of happiness in Polish patients with multiple sclerosis
Introduction. Happiness is crucial to patient well-being and their acceptance of their disease. The aim of this study was to assess the sense of happiness in persons with multiple sclerosis (PwMS), compare it to the level of happiness in patients with other neurological conditions, and determine which factors affect the sense of happiness in PwMS. Material and methods. Five hundred and eighty-nine PwMS and 145 control subjects (post-stroke patients with chronic pain syndromes and neuropathies) were included in the study. Due to the differences between the groups in terms of demographic variables, an adjusted group of PwMS (n = 145) was selected from the entire group of PwMS. All patients were assessed using the Oxford Happiness Questionnaire (OHQ), the Satisfaction with Life Scale (SLS), and the Family APGAR Questionnaire. Based on regression analysis, the study examined which variables affected the level of happiness in the groups. Results. Analysis of the OHQ scores showed that PwMS had a lower sense of happiness compared to the control group in the overall score [113.21 (25–42) vs. 119.88 (25–49), respectively; p = 0.031] and the subscales (OHQ subscale 1 — 54.52 vs. 57.84, respectively; p = 0.027; subscale 2 — 35.61 vs. 37.67; respectively; p = 0.044). Based on linear regression analysis, life satisfaction (β = 0.40; p < 0.001), positive orientation (β = 0.32; p < 0.001), and primary education (β = 0.08; p = 0.009) were the most significant predictors of a higher level of happiness in PwMS. Similar results were found in the control group. Conclusions. The sense of happiness in PwMS was lower than in patients with other conditions. The most important factors influencing happiness included life satisfaction and positive orientation. Influencing these predictors should be the aim of psychological interventions, especially in patients with a reduced sense of happiness
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience
Introduction. The aim of this study was to report the course and outcome of SARS-CoV-2 infection in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs) in Poland. A major concern for neurologists worldwide is the course and outcome of SARS-CoV-2 infection in patients with MS treated with different DMTs. Although initial studies do not suggest an unfavourable course of infection in this group of patients, the data is limited.Materials and methods. This study included 396 MS patients treated with DMTs and confirmed SARS-CoV-2 infection from 28 Polish MS centres. Information concerning patient demographics, comorbidities, clinical course of MS, current DMT use, as well as symptoms of SARS-CoV-2 infection, need for pharmacotherapy, oxygen therapy, and/or hospitalisation, and short-term outcomes was collected up to 30 January 2021. Additional data about COVID-19 cases in the general population in Poland was obtained from official reports of the Polish Ministry of Health.Results. There were 114 males (28.8%) and 282 females (71.2%). The median age was 39 years (IQR 13). The great majority of patients with MS exhibited relapsing-remitting course (372 patients; 93.9%). The median EDSS was 2 (SD 1.38), and the mean disease duration was 8.95 (IQR 8) years. Most of the MS patients were treated with dimethyl fumarate (164; 41.41%). Other DMTs were less frequently used: interferon beta (82; 20.70%), glatiramer acetate (42; 10.60%), natalizumab (35;8.84%), teriflunomide (25; 6.31%), ocrelizumab (20; 5.05%), fingolimod (16; 4.04), cladribine (5; 1.26%), mitoxantrone (3; 0.76%), ozanimod (3; 0.76%), and alemtuzumab (1; 0.25%). The overall hospitalisation rate due to COVID-19 in the cohort was 6.81% (27 patients). Only one patient (0.3%) died due to SARS-CoV-2 infection, and three (0.76%) patients were treated with mechanical ventilation; 106 (26.8%) patients had at least one comorbid condition. There were no significant differences in the severity of SARS-CoV-2 infection regarding patient age, duration of the disease, degree of disability (EDSS), lymphocyte count, or type of DMT used.Conclusions and clinical implications. Most MS patients included in this study had a favourable course of SARS-CoV-2 infection. The hospitalisation rate and the mortality rate were not higher in the MS cohort compared to the general Polish population. Continued multicentre data collection is needed to increase the understanding of SARS-CoV-2 infection impact on the course of MS in patients treated with DMTs
Report from the conference "Adults with Congenital Heart Defects: compendium", Poznan, November 20, 2010
Invasive electrophysiology“Benign” atrial arrhythmias exacerbated by physical activity as a cause of cardiomyopathy
We describe a 39-year-old man with premature atrial contractions at rest, in whom tachycardia was exacerbated by exercise into long-lasting atrial tachycardia of 150 beats/min with changeable grade of AV conduction. The feeling of irregular heart beating was the only symptom of arrhythmia and was well tolerated for many years. However, the signs of tachycardia-mediated cardiomyopathy with heart failure developed over several years. Successful RF ablation of focal atrial tachycardia using the CARTO system was performed. After 5 months of follow-up the patient is free from arrhythmia with a significant improvement of the HF
Storia del ritratto in cera
Cel pracy: Obniżenia odcinka ST występujące podczas ambulatoryjnego monitorowania EKG mogą być użytecznym testem identyfikującym chorych z większym zaawansowaniem choroby wieńcowej. Celem pracy było porównanie dynamiki odcinka ST w badaniu EKG metodą Holtera z elektrokardiograficzną próbą wysiłkową, tomoscyntygrafią perfuzyjną serca oraz koronarografią.
Materiał i metody: Do badań włączono 67 chorych na chorobę wieńcową potwierdzoną angiograficznie, u których wykonano 24-godzinne ambulatoryjne monitorowanie EKG oraz badanie SPECT z zastosowaniem Tc-99m-MIBI. U 40% badanych stwierdzono obniżenia odcinka ST w ciągu doby, natomiast próba wysiłkowa była dodatnia u 88%, a scyntygrafia była nieprawidłowa u wszystkich badanych. Stwierdzono częstsze występowanie epizodów niemego niedokrwienia (40%) w porównaniu z epizodami bólowymi (15%). Pacjenci z niemym niedokrwieniem (40%) charakteryzowali się częstszym występowaniem choroby wielonaczyniowej, krótszym czasem trwania próby wysiłkowej, mniejszym maksymalnym obciążeniem oraz częstszym występowaniem obniżeń odcinka ST, a także większą rozległością zmian niedokrwiennych w scyntygrafii perfuzyjnej serca.
Wnioski: Wyniki przeprowadzonego badania sugerują, że obecność niemego niedokrwienia podczas ambulatoryjnego monitorowania EKG metodą Holtera może identyfikować chorych z czynnościowo bardziej zaawansowaną formą choroby wieńcowej